Results 251 to 260 of about 93,626 (282)

Immune mechanisms and immunomodulatory therapies in steroid-resistant nephrotic syndrome. [PDF]

Ren Fail
Deng J, Zhu L, Zhu X.
europepmc   +1 more source

Towards antibody-based immunotherapy development for platinum-resistant high-grade serous ovarian cancer. [PDF]

Sci Rep
Giedraityte Z, Aarnio N, Nait Mohamed FA, Bjørge L, Meri S.   +4 more
europepmc   +1 more source

Complosome Activation after Myocardial Infarction in a Murine Model of Permanent LAD Ligation. [PDF]

Stem Cell Rev Rep
Ratajczak J, Abdel-Latif A, Schneider G, Luther T, Chaudhary R, Shabani P, Lopez R, Alzamrooni A, Singh AP, Jama H, Kakar SS, Kucia M, Ratajczak M.   +12 more
europepmc   +1 more source

The Role of Complement Component C5a in the Pathogenesis of Diabetic Kidney Disease: A New Kid on the Block? [PDF]

Cureus
Geladari V, Paschou E, Betsikos A, Pallas D, Sabanis N.   +4 more
europepmc   +1 more source

Complement contributes to ICI-triggered sialadenitis and predicts ICI efficacy. [PDF]

Cancer Immunol Immunother
Guan X, Liu M, Li A.
europepmc   +1 more source

Do microenvironmental changes in degenerative disc disease reflect in systemic circulation? A proteomic investigation. [PDF]

Clin Proteomics
Nayagam SM, Palraj ND, Eswaran M, Selvaraj G, Rajendran S, Ramachandran K, Arunachalam D, Tangavel C, K S SA, Raveendran M, Rajasekaran S.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Microvascular deposition of complement membrane attack complex in dermatomyositis.

New England Journal of Medicine, 1986
J. Kissel, J. R. Mendell, K. Rammohan
semanticscholar   +3 more sources

Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease.

Brain Research, 1994
S. Itagaki, H. Akiyama, Hiroki Saito, P. Mcgeer   +3 more
semanticscholar   +3 more sources